0000905148-23-000513.txt : 20230726
0000905148-23-000513.hdr.sgml : 20230726
20230726181836
ACCESSION NUMBER: 0000905148-23-000513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230724
FILED AS OF DATE: 20230726
DATE AS OF CHANGE: 20230726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vazquez Chris
CENTRAL INDEX KEY: 0001980594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 231114865
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0508
4
2023-07-24
0001439725
BIODESIX INC
BDSX
0001980594
Vazquez Chris
2970 WILDERNESS PLACE
SUITE 100
BOULDER
CO
80301
true
Chief Accounting Officer
false
Stock Options (Right to buy)
20.67
2023-07-24
4
D
0
16000
D
2031-02-22
Common Stock
16000
0
D
Stock Options (Right to buy)
1.2
2023-07-24
4
A
0
3266
A
2033-07-23
Common Stock
3266
3266
D
Stock Options (Right to buy)
1.2
2023-07-24
4
A
0
25000
0
A
2033-07-23
Common Stock
25000
25000
D
This option vested 40% on February 23, 2023, and the remaining 60% were scheduled to vest in 36 successive, equal monthly installments measured from February 23, 2023.
On June 23, 2023, the Issuer made an offer (the "Tender Offer") to certain employees to exchange some or all of their outstanding options with an exercise price greater than $10.00 per share (such options properly tendered for exchange, "Surrendered Options") for new options with terms determined in accordance with the terms of the Tender Offer ("Replacement Options"). The Tender Offer closed on July 24, 2023, and the Issuer's board of directors approved the exchange of Surrendered Options for Replacement Options on July 24, 2023.
The Reporting Person elected to participate in the Tender Offer and received 3,266 Replacement Options with an exercise price of $1.20 per share in exchange for 16,000 Surrendered Options with an exercise price of $20.67 per share, after which the Surrendered Options were cancelled.
This Replacement Option vests as follows: 1,579 shares of Common Stock underlying this Replacement Option vest on August 1, 2024, and the remaining 1,687 shares of Common Stock underlying this Replacement Option vest in 31 successive, equal monthly installments beginning on August 1, 2024.
This option vests in a series of 48 successive, equal monthly installments measured from July 24, 2023, subject to the Reporting Person's continuous service through each applicable vesting date.
/s/ Robin H. Cowie as Attorney-in-Fact for Chris Vazquez
2023-07-26